Reversible posterior leucoencephalopathy syndrome associated with bone marrow transplantation

Arquivos de Neuro-Psiquiatria

Volumn 59, Issue 3 B, 2001, Pages 784-789

  Teive, Hélio A G ^a   Brandi, Ivar V ^a   Camargo, Carlos H F ^a   Bittencourt, Marco A ^a   Bonfim, Carmem M ^a   Friedrich, Maria L ^a   De Medeiros, Carlos R ^a   Werneck, Lineu C ^a   Pasquini, Ricardo ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Bone marrow transplantation; Cyclosporine A; Neurological complications

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG WITHDRAWAL; ECLAMPSIA; FEMALE; HEADACHE; HEMISPHERE; HUMAN; HYPERTENSION; HYPERTENSION ENCEPHALOPATHY; IMMUNOSUPPRESSIVE TREATMENT; LEUKOENCEPHALOPATHY; MALE; NEUROTOXICITY; SCHOOL CHILD; SEIZURE; VASCULAR ENDOTHELIUM; WHITE MATTER;

EID: 0034795412     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2001000500024     Document Type: Article

References (31)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 1994;330:827-838.
2. Gallardo D, Ferrà C, Berlanga JJ, et al. Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996;18:1135-1139.
3. Graus F, Saiz A, Sierra J, et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996;46:1004-1009.
4. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leucoencephalopathy syndrome. N Engl J Med 1996;334:494-500.
5. Lanzino G, Cloft H, Hemstreet MK, et al. Reversible posterior leucoencephalopathy following organ transplantation. Description of two cases. Clin Neurol Neurosurg 1997;99:222-226.
6. Patchell RA. Neurological complications of organ transplantation. Ann Neurol 1994;36:688-703.
7. Patchell RA, White CL 3d, Clark AW, et al. Neurologic complications of bone marrow transplantation. Neurology 1985;35:300-306.
8. Teive H, Zétola V, Zanis J Neto, et al. Neurological complications in bone marrow transplantation: analysis of 458 patients. Neurology 1996;46(Suppl 2):A350.
9. Atkinson K, Biggs J, Darveniza P, et al. Cyclosporine associated central nervous system toxicity after bone marrow transplantation. N Engl J Med 1984;310:527.
10. Delanty N, Vaughan C, Frucht S, Stubgen P. Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology 1997;49:686-689.
11. Powles RL, Clink HM, Spence D, et al. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone marrow transplantation. Lancet 1980;327-329.
12. Ferrara JLM, Deeg HJ. Graft-verus-host disease. N Engl J Med 1991;324:667-674.
13. Faulds D, Goa KL, Benfield P. Cyclosporin: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy. Drugs 1993;45:953-1040.
14. Kahan BD. Ciclosporine. N Engl J Med 1989;321:1725-1738.
15. Wasserstein PH, Honig LS. Parkinsonism during cyclosporine treatment. Bone Marrow Transplant 1996;18:649-650.
16. Apsner R, Schulenburg A, Steinhof N, et al. Cyclosporin A induced ocular flutter after marrow transplantation. Bone Marrow Transplant 1997;20:255-256.
17. Aksamit AL, de Groen PC. Cyclosporine-related leucoencephalopathy and PML in a liver transplant recipient. Transplantation 1995;60:874-890.
18. Pace MT, Slovis TL, Kelly JK, Abella SD. Cyclosporin A toxicity: MRI appearance of the brain. Pediatr Radiol 1995;25:180-183.
19. Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporin neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in16 cases. AJR 1995;165:627-631
20. Fogo A, Hakim RC, Sugiura M, et al. Severe endothelial injury in a renal transplant patient receiving Cyclosporine. Transplantation 1990;49:1190-1192.
21. Zoja C, Furci L, Ghilardi F, et al. Cyclosporin-induced endothelial cell injury. Lab Invest 1986;55:455-462.
22. Bunchman TE, Brookshire. Cyclosporin-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 1991;88:310-314.
23. Haug C, Duell T, Lenich A, et al. Elevated plasma endothelin concentrations in cyclosporine-treated patients after bone marrow transplantation. Bone Marrow Transplant 1995;16:191-194
24. Tsakiris DA, Luescher TF, Loeffler BM, et al. Endothelin in the early phase of bone marrow transplantation. Transplantation 1994;57:300.
25. Edvinson L, Owmam C, Sjoberg NO. Autonomic nerves, mast cells, and amina receptors in human brain vessels: a histochemical and pharmacological study. Brain Res 1976;115:377-393.
26. Beausang-Linder M, Bill A. Cerebral circulating in acute hypertension - protective effects of sympathetic nervous activity. Acta Physiol Scand 1981;111:193-199.
27. Reece DE, Frei Lahr DA, Shepard JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393-401
28. Thompson CB, June CH, Sullivan KM, Thoma ED. Association between cyclosporine neurotoxicity and hypomagnesaemia. Lancet 1984;116:1120
29. Lucey MR, Kolars JC, Merion RM, et al. Cyclosporin toxicity at therapeutic blood lavel and cytochrome P-450 IIIA Lancet 1990;335:11-15.
30. Durrant S, Chipping PM, Palmer S, Gordon-Smith EC. Cyclosporin A, methylprednisolone, and convulsions. Lancet 1982;2:829-830.
31. Boogaersts MA, Zachee P, Verwilghen RL. Cyclosporin, methylprednisolone, and convulsions. Lancet. 1982;2:1216-1217.